Delivery Order SPE2DB24D1201-SPE2DB25FJDYL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,102.40 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packaging) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,597.79 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lo Loestrin FE 1-10 Tablet 28-count packages. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a discrete transaction within the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- The Defense Logistics Agency awarded a $1,315.26 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s on August 13, 2025, with completion by August 14, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,498.66 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablet 28-count units on August 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a $3,438.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was made to AmerisourceBergen's Corporate Office division, with performance executed at the company's headquarters in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 18, 2025, by the Defense Logistics Agency for the supply of Lo Loestrin Fe 1-10 tablets (28-count packaging). This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,018.50 with an ultimate completion date of August 19, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,599.91 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive pharmaceutical product. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was awarded without set-aside restrictions through competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDYLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $38,236.07 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lo Loestrin Fe 1/10 tablets in quantities of 28 units. This non-competitive, firm fixed-price delivery order is set to be completed by August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line item pharmaceutical delivery executed under the company's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor supplying a broad range of medications, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The Lo Loestrin Fe delivery represents a routine pharmaceutical supply execution within the company's ongoing role as a primary vendor for federal military medical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.2k | 8/19/25 |